Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Sarcoma 14 Ovarian Neoplasms 6 Neoplasms 5 Liposarcoma 5 Leiomyosarcoma 5 Liposarcoma, Myxoid 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neoplasms by Site 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Ichthyosis, X-Linked 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Solitary Fibrous Tumors 1 Soft Tissue Neoplasms 1 Skin Diseases 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Recurrent High Grade Meningioma 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Mesothelioma 1 Malignant mesenchymal tumor 1

Interventions

Pemetrexed 10 Cisplatin 9 Gemcitabine 8 Nivolumab 5 Ipilimumab 4 Carboplatin 4 niraparib 3 durvalumab 3 Vinorelbine 3 Bevacizumab 3 tremelimumab 2 pembrolizumab 2 olaparib 2 anetumab ravtansine 2 Radiotherapy, Intensity-Modulated 2 Oxaliplatin 2 Imatinib Mesylate 2 Hyperthermic Intraperitoneal Chemotherapy 2 Fluorodeoxyglucose F18 2 Cytoreduction Surgical Procedures 2 vandetanib 1 tislelizumab 1 tazemetostat 1 spartalizumab 1 sargramostim 1 ribociclib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma × Trabectedin × Clear all

NCT02194231 2020-01-23

ATREUS

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡